telmisartan has been researched along with Colonic Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Chrzanowska, A; Filipek, A; Graboń, W; Mielczarek-Puta, M; Otto-Ślusarczyk, D | 1 |
Higashiyama, S; Inoue, Y; Ishiguro, H; Joh, T; Kamiya, T; Kataoka, H; Mizoshita, T; Morimoto, C; Nishiwaki, E; Ozeki, K; Shimura, T; Tanida, S; Tsukamoto, H | 1 |
Kochi, T; Kubota, M; Moriwaki, H; Ohno, T; Sakai, H; Shimizu, M; Tanaka, T; Tsurumi, H; Yasuda, Y | 1 |
3 other study(ies) available for telmisartan and Colonic Neoplasms
Article | Year |
---|---|
Telmisartan Influences the Antiproliferative Activity of Linoleic Acid in Human Colon Cancer Cells.
Topics: Antihypertensive Agents; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Drug Therapy, Combination; Humans; Linoleic Acid; PPAR gamma; Telmisartan | 2020 |
Telmisartan inhibits cell proliferation by blocking nuclear translocation of ProHB-EGF C-terminal fragment in colon cancer cells.
Topics: Benzimidazoles; Benzoates; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Colonic Neoplasms; Heparin-binding EGF-like Growth Factor; Humans; Intercellular Signaling Peptides and Proteins; Phorbol Esters; Protein Transport; Telmisartan | 2013 |
Renin-angiotensin system inhibitors suppress azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Azoxymethane; Benzimidazoles; Benzoates; Captopril; Colonic Neoplasms; Cyclooxygenase 2; Deoxyguanosine; Interleukin-1beta; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Obesity; Oxidative Stress; Plasminogen Activator Inhibitor 1; Precancerous Conditions; Renin-Angiotensin System; RNA, Messenger; Telmisartan; Tumor Necrosis Factor-alpha | 2011 |